Trial intelligence / Profile preview

S-pantoprazole sodium vs pantoprazole sodium for injection in acute upper gastrointestinal ulcer bleeding

CTR20202353Phase 3Terminated

Sponsor
Chia Tai-Tianqing Pharmaceutical Group
Start
Nov 2020
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of s-pantoprazole in upper gastrointestinal bleeding (UGIB), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Nov 2020; status: terminated.

02

Drugs

s-pantoprazole
03

Conditions

upper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on CTR20202353.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20202353.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call